Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+Belgian Central Sleep Apnea REgistryLong-Term Study Of CP-690,550 In Subjects With Ulcerative ColitisA Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative ColitisProcalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients.Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell TransfusionsA Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302)Detection of Atrial Fibrillation in Different Patient Target Groups Using the FibriCheck Smartphone ApplicationEffect Low Pressure Pneumoperitoneum and Pulmonary Recruitment on Postoperative PainWeekly Paclitaxel/Carboplatin With Neupogen in Gynaecological CancersSwitching From Adalimumab to InfliximabA Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerStudy of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HLA Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)Evaluating Quality and Cost of (Partial) Oncological Home-HospitalizationFixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World SettingEfficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple SclerosisPEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer MetastasesObservational Study to Confirm Safety and Efficacy of the ROADSAVER Stent for the Treatment of Carotid Artery StenosisEfficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerA Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal AntiboA Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Surgically Unresectable Urothelial Cancer With Selected FGFR GeneA Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid TumorsA Study of Mirikizumab (LY3074828) in Participants With Crohn's DiseaseTrastuzumab Deruxtecan (DS-8201a) With Nivolumab in Advanced Breast and Urothelial CancerStudy of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by ChemiotherapyA Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate CancerStellarex Vascular E-RegistrytaPentadol cLinical prAcTice IN belgiUMAn Efficacy and Safety Study of SHP647 as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
P6153
Q61894581-3368DA71-E1B5-4440-B4B1-FE1EBDB1E3E1Q61902566-690CA2F6-A22E-416D-963E-3399B1EC61ECQ61955644-DEF1BA7D-E069-4185-A58F-4FFFDA85DF2CQ61965863-4A4FB54D-E94D-42C1-A445-91C355E8DEC3Q62054716-6665B5AA-2DAB-4DED-82D2-0F8002E45EA5Q62054807-E2A9C648-A21F-4A39-A908-3A39C3ECDDB2Q62062674-839FE80A-B95F-4894-AFE7-4181640A469CQ62821405-9B09DC63-FA70-4327-8B88-8A433F1EEFA1Q63229166-FA53A61C-CF05-4441-B79A-F85315F4F119Q63319485-DE43320E-9F00-4946-9FC8-A9A972FB6A74Q63335309-E3BBEA6F-0A30-40E8-B1F1-819EB222A156Q63335890-0270FCAF-691D-4E40-AF35-044BABD9E8F6Q63335936-8FA5CA82-2AA3-45DE-9ABF-1704A7627994Q63337033-798B21A8-28DC-4D9F-8D50-F688D58053EAQ63393063-E7F07BAA-091D-4849-825E-3BCC5D8F012BQ63393438-C7A8D4E7-113A-4CB8-AD9C-9EF08ECBB949Q63393569-5B31BD03-F9E1-4BE4-ABBE-B2E4C526BFB7Q63394983-6AE30BDF-1069-43E8-8228-3F799DCA1961Q63397653-D358B83F-DC29-4CFE-AA91-7DCC005FF719Q63398014-FDCD2E3F-0D1D-4D87-B14C-86AB5E9F1953Q63398075-9DE51135-EAD0-4AE6-BFFB-CDA9CF5DDB22Q63404016-CF774DAE-0C43-4782-AC94-EDE1E4A9724FQ63571469-C77B283A-F585-4B92-8F92-29A67A486F50Q63571964-063939C3-3C09-4054-8908-A2591BC4F622Q63572819-2FB6F4A6-C7E0-4F6B-8340-34C7C0DDC195Q63572882-49745F11-8859-438F-A350-DA830B142098Q64150620-FC4DA8FF-7526-42D6-B707-5BB6595105FBQ64150677-D2FC97CF-D63F-4A50-B787-53C244BB1CEFQ64151685-188A9307-B9BA-43AF-AD97-2F5E555750DAQ64172768-7439A08E-C96C-4959-8916-82F863E25B2CQ64172932-39CB448F-9AA4-4CD7-AEAA-CE0DE1359E39Q64173024-D19BB698-AE45-4EC8-BA10-5E988237CE44Q64187883-D7B529E8-A7F2-41D2-9B38-C2305579F06B
P6153
description
Flemish hospital association
@en
Krankenhaus
@de
griya sakit
@jv
hospital de Bélxica
@ast
hôpital
@fr
rumah sakik
@min
rumah sakit di Belgia
@id
rumoh sakét
@ace
ziekenhuis in België
@nl
בית חולים בבלגיה
@he
name
AZ Groeninge
@en
AZ Groeninge
@fr
AZ Groeninge
@nl
بیمارستان خرونینگن
@fa
type
label
AZ Groeninge
@en
AZ Groeninge
@fr
AZ Groeninge
@nl
بیمارستان خرونینگن
@fa
prefLabel
AZ Groeninge
@en
AZ Groeninge
@fr
AZ Groeninge
@nl
بیمارستان خرونینگن
@fa
P6366
P646
P131
P17
P213
0000 0004 0626 4023
P2427
grid.420028.c
P571
2003-01-01T00:00:00Z
P625
Point (3.265744 50.801347)
P6366
2800286501
P646
/m/09ry1b6